Works about CHIMERIC antigen receptors
Results: 3065
Checkmate awaiting strategy: unlocking the potential of chimeric antigen receptor T-cell therapy in uveal melanoma.
- Published in:
- Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1555842
- By:
- Publication type:
- Article
New hopes and challenges in targeted therapy and immunotherapy for primary central nervous system lymphoma.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1438001
- By:
- Publication type:
- Article
Elevated CD10<sup>−</sup> neutrophils correlate with non-response and poor prognosis of CD19 CAR T-cell therapy for B-cell acute lymphoblastic leukemia.
- Published in:
- BMC Medicine, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12916-025-03968-5
- By:
- Publication type:
- Article
Use of a universal targeting CAR T cell to simultaneously kill cancer cells and cancer-associated fibroblasts.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1539265
- By:
- Publication type:
- Article
Recent Progress in Engineered Oncolytic Viruses: A Thematic Review.
- Published in:
- 2024
- By:
- Publication type:
- Literature Review
Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.
- Published in:
- Acta Neuropathologica Communications, 2025, v. 13, n. 1, p. 1, doi. 10.1186/s40478-025-01965-6
- By:
- Publication type:
- Article
BCMA-targeted therapies for multiple myeloma: latest updates from 2024 ASH annual meeting.
- Published in:
- Journal of Hematology & Oncology, 2025, v. 18, n. 1, p. 1, doi. 10.1186/s13045-025-01675-5
- By:
- Publication type:
- Article
Expanding the Horizons of CAR-T Cell Therapy: A Review of Therapeutic Targets Across Diverse Diseases.
- Published in:
- Pharmaceuticals (14248247), 2025, v. 18, n. 2, p. 156, doi. 10.3390/ph18020156
- By:
- Publication type:
- Article
GRP78 in Glioma Progression and Therapy: Implications for Targeted Approaches.
- Published in:
- Biomedicines, 2025, v. 13, n. 2, p. 382, doi. 10.3390/biomedicines13020382
- By:
- Publication type:
- Article
Exploring CAR-PBMCs: A Novel Strategy Against EGFR-Positive Tumor Cells.
- Published in:
- Biomedicines, 2025, v. 13, n. 2, p. 264, doi. 10.3390/biomedicines13020264
- By:
- Publication type:
- Article
Impact of Prior Selinexor Exposure on Outcomes of Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: An Exploratory Analysis.
- Published in:
- Journal of Clinical Medicine, 2025, v. 14, n. 4, p. 1316, doi. 10.3390/jcm14041316
- By:
- Publication type:
- Article
Current Issues and Future Perspectives of Targeted Therapies in Primary Mediastinal Large B-Cell Lymphoma.
- Published in:
- Journal of Clinical Medicine, 2025, v. 14, n. 4, p. 1191, doi. 10.3390/jcm14041191
- By:
- Publication type:
- Article
Long-term remission following CAR-T therapy in a patient with transformed follicular lymphoma relapse after allogeneic stem cell transplantation.
- Published in:
- Annals of Hematology, 2025, v. 104, n. 1, p. 841, doi. 10.1007/s00277-024-06150-8
- By:
- Publication type:
- Article
Clinical outcomes and safety of CAR-T cells in treatment of T-Cell acute lymphoblastic leukemia/lymphoma.
- Published in:
- Annals of Hematology, 2025, v. 104, n. 1, p. 57, doi. 10.1007/s00277-024-06132-w
- By:
- Publication type:
- Article
Tumor-Associated Extracellular Matrix Obstacles for CAR-T Cell Therapy: Approaches to Overcoming.
- Published in:
- Current Oncology, 2025, v. 32, n. 2, p. 79, doi. 10.3390/curroncol32020079
- By:
- Publication type:
- Article
Clinical Proof-of-Concept of a Non-Gene Editing Technology Using miRNA-Based shRNA to Engineer Allogeneic CAR T-Cells.
- Published in:
- International Journal of Molecular Sciences, 2025, v. 26, n. 4, p. 1658, doi. 10.3390/ijms26041658
- By:
- Publication type:
- Article
Unlocking the Role of Treg Cells Immune Response and Infectious Risk Following CAR T-Cell Therapy in Patients with Cancer.
- Published in:
- International Journal of Molecular Sciences, 2025, v. 26, n. 4, p. 1602, doi. 10.3390/ijms26041602
- By:
- Publication type:
- Article
CAR-T therapy for endocrine neoplasms: novel targets and combination of therapies.
- Published in:
- Frontiers in Endocrinology, 2025, p. 1, doi. 10.3389/fendo.2025.1517525
- By:
- Publication type:
- Article
Optimization of canine CD20 chimeric antigen receptor T cell manufacturing and in vitro cytotoxic activity against B‐cell lymphoma.
- Published in:
- Veterinary & Comparative Oncology, 2020, v. 18, n. 4, p. 739, doi. 10.1111/vco.12602
- By:
- Publication type:
- Article
Engineered Nanomaterials for Tumor Immune Microenvironment Modulation in Cancer Immunotherapy.
- Published in:
- Chemistry - A European Journal, 2024, v. 30, n. 32, p. 1, doi. 10.1002/chem.202400425
- By:
- Publication type:
- Article
Design, Synthesis, and Targeted Delivery of an Immune Stimulant that Selectively Reactivates Exhausted CAR T Cells.
- Published in:
- Angewandte Chemie, 2022, v. 134, n. 15, p. 1, doi. 10.1002/ange.202113341
- By:
- Publication type:
- Article
Titelbild: A Reversible Chemogenetic Switch for Chimeric Antigen Receptor T Cells (Angew. Chem. 10/2022).
- Published in:
- Angewandte Chemie, 2022, v. 134, n. 10, p. 1, doi. 10.1002/ange.202201860
- By:
- Publication type:
- Article
A Reversible Chemogenetic Switch for Chimeric Antigen Receptor T Cells**.
- Published in:
- Angewandte Chemie, 2022, v. 134, n. 10, p. 1, doi. 10.1002/ange.202109550
- By:
- Publication type:
- Article
Improving Cancer Immunotherapy Outcomes Using Biomaterials.
- Published in:
- Angewandte Chemie, 2020, v. 132, n. 40, p. 17484, doi. 10.1002/ange.202002780
- By:
- Publication type:
- Article
Chemically Programmable and Switchable CAR‐T Therapy.
- Published in:
- Angewandte Chemie, 2020, v. 132, n. 29, p. 12276, doi. 10.1002/ange.202005432
- By:
- Publication type:
- Article
Characterization of supercontinuum generation in a photonic crystal fiber for uses in multiplex CARS microspectroscopy.
- Published in:
- Journal of Raman Spectroscopy, 2019, v. 50, n. 9, p. 1287, doi. 10.1002/jrs.5599
- By:
- Publication type:
- Article
VAV1‐overexpressing YT cells display improved cytotoxicity against malignant cells.
- Published in:
- Biotechnology & Applied Biochemistry, 2021, v. 68, n. 4, p. 849, doi. 10.1002/bab.2001
- By:
- Publication type:
- Article
Glycan-directed CAR-T cells.
- Published in:
- Glycobiology, 2018, v. 28, n. 9, p. 656, doi. 10.1093/glycob/cwy008
- By:
- Publication type:
- Article
Cancer Immunotherapy.
- Published in:
- Glycobiology, 2018, v. 28, n. 9, p. 638, doi. 10.1093/glycob/cwy069
- By:
- Publication type:
- Article
Chimeric Antigen Receptor T-Cell Therapy: The Way Forward!
- Published in:
- Global Journal of Transfusion Medicine, 2021, v. 6, n. 2, p. 118, doi. 10.4103/gjtm.gjtm_88_21
- By:
- Publication type:
- Article
DNA origami assembled spheroid for evaluating cytotoxicity and infiltration of chimeric antigen receptor macrophage (CAR-M).
- Published in:
- Communications Biology, 2024, v. 7, n. 1, p. 1, doi. 10.1038/s42003-024-07009-4
- By:
- Publication type:
- Article
Vaccine Boosting CAR-T Cell Therapy: Current and Future Strategies.
- Published in:
- Advances in Cell & Gene Therapy, 2023, p. 1, doi. 10.1155/2023/8030440
- By:
- Publication type:
- Article
Partnering with patients to get better outcomes with chimeric antigen receptor T-cell therapy: towards engagement of patients in early phase trials.
- Published in:
- Research Involvement & Engagement, 2020, v. 6, n. 1, p. N.PAG, doi. 10.1186/s40900-020-00230-5
- By:
- Publication type:
- Article
Imunoterapia în bolile neoplazice.
- Published in:
- Farmacist.ro, 2022, n. 1, p. 16
- By:
- Publication type:
- Article
Emerging advances in nano-biomaterial assisted amyloid beta chimeric antigen receptor macrophages (CAR-M) therapy: reducing plaque burden in Alzheimer's disease.
- Published in:
- Journal of Drug Targeting, 2025, v. 33, n. 2, p. 185, doi. 10.1080/1061186X.2024.2417012
- By:
- Publication type:
- Article
Designed allosteric protein logic.
- Published in:
- Cell Discovery, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41421-023-00635-y
- By:
- Publication type:
- Article
Safety and feasibility of anti-CD19 CAR T cells expressing inducible IL-7 and CCL19 in patients with relapsed or refractory large B-cell lymphoma.
- Published in:
- Cell Discovery, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41421-023-00625-0
- By:
- Publication type:
- Article
Treatment of allergic eosinophilic asthma through engineered IL-5-anchored chimeric antigen receptor T cells.
- Published in:
- Cell Discovery, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41421-022-00433-y
- By:
- Publication type:
- Article
Human herpesvirus 6 (HHV-6) encephalitis secondary to chimeric antigen receptor (CAR)-T cell therapy.
- Published in:
- Neurological Sciences, 2025, v. 46, n. 3, p. 1323, doi. 10.1007/s10072-024-07860-7
- By:
- Publication type:
- Article
Extracorporeal cytokine adsorption as therapeutic option for immune effector cell-associated neurotoxicity syndrome.
- Published in:
- Neurological Sciences, 2025, v. 46, n. 1, p. 479, doi. 10.1007/s10072-024-07812-1
- By:
- Publication type:
- Article
Correction to: Primary vs. pre-emptive anti-seizure medication prophylaxis in anti-CD19 CAR T-cell therapy.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Pre-existing frontal lobe dysfunction signs as predictors of subsequent neurotoxicity in CAR T cell therapy: insights from a case series.
- Published in:
- Neurological Sciences, 2023, v. 44, n. 9, p. 3291, doi. 10.1007/s10072-023-06841-6
- By:
- Publication type:
- Article
Wolfgang Grisold, Riccardo Soffietti, Stefan Oberndorfer, Guido Cavaletti (eds): Effects of cancer treatment on the nervous system : Cambridge Scholars Publishing, 2020-2021, Volumes 1 and 2.
- Published in:
- 2021
- By:
- Publication type:
- journal article
An In Vitro Comparison of Costimulatory Domains in Chimeric Antigen Receptor T Cell for Breast Cancer Treatment.
- Published in:
- 2022
- By:
- Publication type:
- journal article
CAR SCRAP YARDS NETWORK IN SLOVAKIA.
- Published in:
- Economics: Innovative & Economic Research Journal / Casopis za Ekonomsku Teoriju i Analizu, 2019, v. 7, n. 1, p. 51, doi. 10.2478/eoik-2019-0001
- By:
- Publication type:
- Article
Health-related quality of life dynamics: modeling insights from immunotherapy.
- Published in:
- Quality of Life Research, 2025, v. 34, n. 1, p. 273, doi. 10.1007/s11136-024-03810-0
- By:
- Publication type:
- Article
Severe cases of local cytokine release syndrome (CRS); craniocervical edema soon after chimeric antigen T-cell (CAR-T) therapy.
- Published in:
- Oxford Medical Case Reports, 2025, v. 2025, n. 1, p. 1, doi. 10.1093/omcr/omae164
- By:
- Publication type:
- Article
Sweet T-bursting is the subiculum's true badge.
- Published in:
- Journal of Physiology, 2017, v. 595, n. 19, p. 6223, doi. 10.1113/JP274981
- By:
- Publication type:
- Article
CAR T vs CAR NK Cells: Big Hunt for the Right Tool.
- Published in:
- Malaysian Journal of Medicine & Health Sciences, 2023, v. 19, p. 33
- By:
- Publication type:
- Article
Experience of Harvesting Lymphocyte for CAR-T Cell Therapy in University Malaya Medical Centre During the COVID Pandemic.
- Published in:
- Malaysian Journal of Medicine & Health Sciences, 2023, v. 19, p. 7
- By:
- Publication type:
- Article